Abstract:Objective: Bipolar disorder (BD) is a debilitating neuropsychiatric disorder, which is associated with genetic variation through "vast but mixed" Genome-Wide Association Studies (GWAS). Transcriptome-Wide Association Study (TWAS) is more effective in explaining genetic factors that influence complex diseases and can help identifying risk genes more reliably. So, this study aims to identify potential BD risk genes in pedigrees with TWAS. Methods: We conducted a TWAS analysis with expression quantitative trait loci (eQTL) analysis on extended BD pedigrees, and the BD genome-wide association study (GWAS) summary data acquired from the Psychiatric Genomics Consortium (PGC). Furthermore, the BD-associated genes identified by TWAS were validated by mRNA expression profiles from the Gene Expression Omnibus (GEO) Datasets (GSE23848 and GSE46416). Functional enrichment and annotation analysis were implemented by RStudio (version 4.2.0). Results: TWAS identified 362 genes with P value < 0.05, and 18 genes remain significant after Bonferroni correction, such as SEMA3G (PTWAS=1.07 × 10-11), ALOX5AP (PTWAS=3.12 × 10-8), and PLEC (PTWAS=1.27 × 10-7). Further 6 overlapped genes were detected in integrative analysis, such as UQCRB (PTWAS=0.0020, PmRNA=0.0000), TMPRSS9 (PTWAS=0.0405, PmRNA=0.0032), and SNX10 (PTWAS=0.0104, PmRNA=0.0015). Using genes identified by TWAS, Gene Ontology (GO) enrichment analysis identified 40 significant GO terms, such as mitochondrial ATP synthesis coupled electron transport, mitochondrial respiratory, aerobic electron transport chain, oxidative phosphorylation, mitochondrial membrane proteins, and ubiquinone activity. The Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway enrichment analysis identified significant 15 pathways for BD, such as Oxidative phosphorylation, endocannabinoids signaling, neurodegeneration, and reactive oxide species. Conclusions: We found a set of BD-associated genes and pathways, validating the important role of neurodevelopmental abnormalities, inflammatory responses, and mitochondrial dysfunction in the pathology of BD, offering novel information for comprehending the genetic basis of BD.

Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance

Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression

Biological and Psychosocial Predictors of Postpartum Depression: Systematic Review and Call for Integration

Lucky Gene 5-HTTLPR and Postpartum Depression: A Systematic Review

Perinatal depression and DNA methylation of oxytocin-related genes: a study of mothers and their children

Clinical Features and Risk Factors for Post-Partum Depression in A Large Cohort of Chinese Women with Recurrent Major Depressive Disorder

919 granules improve postpartum depression through the regulation of abnormal peripheral blood IL-1β

Identification of risk loci for postpartum depression in a genome‐wide association study

Postpartum Depression: Current Status and Possible Identification Using Biomarkers

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Integrative analysis of transcriptome-wide association study and mRNA expression profile identified risk genes for bipolar disorder

Bridging Neurobiological Insights and Clinical Biomarkers in Postpartum Depression: A Narrative Review

The role of gut microbiota and blood metabolites in postpartum depression: a Mendelian randomization analysis

Biological Aspects of Postpartum Depression

Linking the reversal of gestational insulin resistance to postpartum depression

Postpartum depression: psychoneuroimmunological underpinnings and treatment

Risk factors for postpartum depression in Chinese women: A cross-sectional study at 6 weeks postpartum

Postpartum depression and autoimmune disease: a bidirectional Mendelian randomization study

PPD ACT: an app-based genetic study of postpartum depression

Causal relationship between Women's reproductive traits and postpartum depression: a multivariate mendelian randomization analysis